article thumbnail

Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends

Express Pharma

The nutraceutical market began to gain traction around 2005-2010, growing steadily since then. Products in this category are often prescribed by practitioners, such as nephrologists for renal care or diabetologists for managing diabetes. People started understanding the importance of maintaining their health proactively.

article thumbnail

Meeting the Unique Health Needs of AANHPI Communities: The Case for Cultural Humility

Putting Patients First Blog

For example: Diabetes According to the Centers for Medicare and Medicaid Services , among Asian Americans, the diagnosed diabetes rate is 9.2%; this varies significantly by subgroupas high as 12.2% Cancer incidence rates among AANHPI subgroups from 2006-2010 ranged from 216.8 for Asian Indians and 10.4% for Chinese Americans.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacy Times

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2014 Jul 15;59(2):e10-52. doi:10.1093/cid/ciu444. Clin Infect Dis.

article thumbnail

Is DTC pharma advertising coming to an end?

PharmaVoice

In particular, Sanders called out Eli Lilly for spending $205 million on advertising in 2010 for its antidepressant drug Cymbalta, which brought in $3.2 In fact, GLP-1s have lifted the industry’s overall marketing spend, which is “ skyrocketing among drugmakers and healthcare companies,” for obesity and diabetes ads, eMarketer found.

article thumbnail

GRIN Therapeutics: Seeking to address unmet needs in rare neurodevelopmental disorders

pharmaphorum

Skip to main content Monday 30 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

207 community hospital presidents and CEOs to know | 2025

Beckers Hospital Review

Since rejoining Princeton Health in 2010, Mr. Demetriades has guided the system through major transitions, including its 2018 integration into Philadelphia-based Penn Medicine. Mr. Lauf has overseen operations for Cape Cod Healthcare’s 450 physicians and 5,300 employees since December 2010. Michael Lauf.

article thumbnail

FDA rejects Provention’s type 1 diabetes drug teplizumab

pharmaphorum

The FDA indicated something was not well with Provention Bio’s filing for type 1 diabetes therapy teplizumab in April when it delayed its review. The post FDA rejects Provention’s type 1 diabetes drug teplizumab appeared first on.